trending Market Intelligence /marketintelligence/en/news-insights/trending/k65gsrg6wgimi1arphurlg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

OptimizeRx buys medication reminder services provider CareSpeak

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


OptimizeRx buys medication reminder services provider CareSpeak

OptimizeRx Corp. said it acquired Somerset, N.J.-based CareSpeak Communications Inc., a provider of messaging services to remind patients about their medications.

Under the deal, OptimizeRx paid $5.5 million in cash, as well as $500,000 in company stock and may make earnout payments of up to $3 million based on certain revenue targets for 2019 and 2020.

In addition, the company incurred its own expenses for the transaction at about $500,000.

The company acquired the shares from CareSpeak CEO Srdjan Loncar, United HealthCare Services Inc., Christopher DiCostanzo and Kresimir Nesek.

Rochester, Mich.-based OptimizeRx operates a digital health messaging platform by using electronic health records to connect drugmakers with healthcare services providers.

OptimizeRx said the acquisition of privately held CareSpeak will expand its reach directly to patients resulting in greater medication adherence and affordability.

CareSpeak is expected to report revenues above $1 million in 2018 and also achieve profitability by the end of the year.

About 25% to 50% of patients worldwide fail to take their medicines as prescribed, the companies said citing a recent study, adding that non-adherence to medications in the U.S. has been associated with 125,000 deaths and 10% of hospitalizations annually.